Interestingly, expression and activation of Dmp1:ER in the ARF+P53 wild-type lung cancer cell line strongly inhibited the growth of the cells, while other lung cancer cells with deletion of ARF or P53 were relatively resistant (Mallakin et al. 2007). This evidence concerns the gene CDKN2A and lung cancer.